Skip to main content
ZERUN CO., LTD logo

ZERUN CO., LTD — Investor Relations & Filings

Ticker · 301636 ISIN · CNE100006YN5 Shenzhen Stock Exchange Manufacturing
Filings indexed 159 across all filing types
Latest filing 2025-10-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301636

About ZERUN CO., LTD

https://www.zerun-tech.com/cn

ZERUN CO., LTD. specializes in the research, development, and commercialization of innovative human vaccines. The organization utilizes advanced recombinant protein technology platforms to address significant public health challenges. Its primary product portfolio includes human papillomavirus (HPV) vaccines, specifically bivalent and nonavalent candidates designed to prevent cervical cancer. ZERUN CO., LTD. emphasizes the production of high-quality, affordable biological products to support global immunization efforts. The organization maintains rigorous quality control standards and operates large-scale manufacturing facilities to ensure the stable supply of preventive medicines. By leveraging its proprietary technical expertise, the company aims to improve health outcomes through the prevention of infectious diseases and virus-related malignancies.

Recent filings

Filing Released Lang Actions
关于签订募集资金四方监管协议的公告
Regulatory Filings
2025-10-17 Chinese
2025年半年度权益分派实施公告
Regulatory Filings
2025-09-23 Chinese
申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司2025年半年度跟踪报告
Regulatory Filings
2025-09-15 Chinese
2025年半年度募集资金存放、管理与使用情况的专项报告
Regulatory Filings
2025-08-26 Chinese
监事会决议公告
Regulatory Filings
2025-08-26 Chinese
关于2025年中期利润分配预案的公告
Regulatory Filings
2025-08-26 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.